The EAP Prescription Drug Toolkit and Fact Sheets provide guidance related to counseling, referrals, and follow-up services (e.g., alternatives to prescription drugs, workplace drug misuse and relapse prevention, dangers of combined drug use, screenings, and evaluations before returning to work).

This Advisory, based on TIP 49, Incorporating Alcohol Pharmacotherapies Into Medical Practice, focuses on medication and related treatment decisions made after screening and assessment for AUD, and medically supervised withdrawal, if necessary. Alcohol consumption should not stop abruptly in those patients who have consumed alcohol regularly over a prolonged period of time. This Advisory is meant as an overview of AUD medications to facilitate abstinence.

Designed for organizations that provide services to older adults, this toolkit offers information and materials to help understanding the issues associated with substance misuse and mental illness in older adults. The toolkit also contains materials to educate older adults.

This guide reviews screening tools for alcohol use and interventions for pregnant women and women of childbearing age to prevent fetal alcohol spectrum disorders (FASD). It also outlines methods for identifying people living with FASD and modifying treatment accordingly. Access the literature review.

This guide describes core elements of screening, brief intervention, and referral to treatment (SBIRT) programs for people living with or at risk for substance use disorders. It provides information on implementing SBIRT services and covering challenges, barriers, cost, and sustainability.

This manual offers mental health professionals models and techniques for working with people living with co-occurring disorders. It describes screening and assessment and lists five guiding principles for effective management.

This manual guides counselors in the use of medications to help clients achieve abstinence from alcohol. It describes how the medications work and whom may benefit. It also presents the side effects of three FDA-approved medications: acamprosate, disulfiram, and naltrexone.

This toolkit offers tools to implement the evidence-based practice of Assertive Community Treatment (ACT). ACT offers customized, community-based services for people living with mental illness. The toolkit includes a brochure (English, Spanish), a PowerPoint presentation, and an introductory video.

This white paper report identifies and proposes strategies to address Medicaid and other reimbursement policies that may pose barriers to mental health services in primary care settings. It presents findings, discussion by an expert panel, and recommended action steps.